Article

Molecular Features of Androgen-Receptor Low, Estrogen Receptor-Negative Breast Cancers in the Carolina Breast Cancer Study

2023-03-22

Abstract excerpt

<title>Abstract</title> <p>Purpose: Androgen receptor (AR) expression is absent in 40-90% of estrogen receptor (ER)-negative breast cancers. The prognostic value of AR in ER-negative patients and therapeutic targets for patients absent in AR remains poorly explored. <h4>Methods:</h4> We used an RNA-based multigene classifier to identify AR-low and AR-high ER-negative participants in the Carolina Breast Cancer Stu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6ae15a64-efed-5389-8f15-7ca2ce60d601
DOI: 10.21203/rs.3.rs-2693555/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Molecular Features of Androgen-Receptor Low, Estrogen Receptor-Negative Breast Cancers in the Carolina Breast Cancer StudyDOI 10.21203/rs.3.rs-2693555/v1Read

Integrative analysis of pre-treatment RNA expression signatures and recurrent genomic alterations: Link to menopausal status, short-term endocrine therapy response and disease-free survival in luminal breast cancerSemantic proximity Read

Assessing the Androgen Receptor Status in Clinicopathologic and Hematologic Characteristics of the Triple-negative Breast CancerSemantic proximity Read

Race specific differences in DNA damage repair dysregulation in breast cancer and association with outcomeSemantic proximity Read

An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen.Semantic proximity Read

Breast cancer in Adolescent & Young Adult (AYA) has a specific biology and poor patient outcome compared to older patientsSemantic proximity Read

Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast CancerSemantic proximity Read

Molecular intrinsic subtypes, genomic and immune landscapes of BRCA-proficient but HRD-high ER-positive/HER2-negative early breast cancersSemantic proximity Read

RNA-Based Classification of Homologous Recombination Deficiency in Racially Diverse Patients with Breast CancerSemantic proximity Read

The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers.Semantic proximity Read

Molecular intrinsic subtypes, genomic, and immune landscapes of BRCA-proficient but HRD-high ER-positive/HER2-negative early breast cancersSemantic proximity Read

Whole genome sequencing of locally advanced and metastatic breast carcinoma unravels relevant molecular signatures and novel events.Semantic proximity Read

Acquired mutations and transcriptional remodeling in long-term estrogen-deprived locoregional breast cancer recurrencesSemantic proximity Read